RA Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,184,456
| Closed | -$230M | – | 91 |
|
2024
Q3 | $230M | Buy |
1,184,456
+202,317
| +21% | +$39.2M | 2.65% | 10 |
|
2024
Q2 | $228M | Buy |
982,139
+241,412
| +33% | +$56M | 3.01% | 6 |
|
2024
Q1 | $160M | Buy |
740,727
+207,835
| +39% | +$44.8M | 2.03% | 13 |
|
2023
Q4 | $138M | Hold |
532,892
| – | – | 2.15% | 9 |
|
2023
Q3 | $137M | Hold |
532,892
| – | – | 2.7% | 6 |
|
2023
Q2 | $152M | Hold |
532,892
| – | – | 2.87% | 6 |
|
2023
Q1 | $148M | Hold |
532,892
| – | – | 3.35% | 6 |
|
2022
Q4 | $148M | Sell |
532,892
-404,657
| -43% | -$112M | 2.99% | 9 |
|
2022
Q3 | $250M | Buy |
937,549
+210,525
| +29% | +$56.2M | 5.34% | 2 |
|
2022
Q2 | $148M | Hold |
727,024
| – | – | 3.95% | 2 |
|
2022
Q1 | $153M | Buy |
+727,024
| New | +$153M | 3.34% | 2 |
|
2015
Q3 | – | Sell |
-2,600
| Closed | -$1.05M | – | 54 |
|
2015
Q2 | $1.05M | Hold |
2,600
| – | – | 0.11% | 51 |
|
2015
Q1 | $1.1M | Hold |
2,600
| – | – | 0.11% | 50 |
|
2014
Q4 | $883K | Hold |
2,600
| – | – | 0.09% | 43 |
|
2014
Q3 | $860K | Buy |
+2,600
| New | +$860K | 0.1% | 35 |
|